Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro.
AUTOR(ES)
Tariq, V N
RESUMO
Interactions between six compounds (econazole, miconazole, amphotericin B, nystatin, nikkomycin Z, and ibuprofen) were investigated for their antifungal activities against Candida albicans by using pair combinations in an in vitro decimal assay for additivity based on disk diffusion. Additive interactions were observed between miconazole and econazole, amphotericin B and nystatin, and amphotericin B and ibuprofen, while an antagonistic interaction was observed between econazole and amphotericin B. Synergistic interactions were recorded for the combinations of econazole and ibuprofen, econazole and nikkomycin Z, and ibuprofen and nikkomycin Z.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=162999Documentos Relacionados
- Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro.
- Decimal assay for additivity of drugs permits delineation of synergy and antagonism.
- Sensitivity to nikkomycin Z in Candida albicans: role of peptide permeases.
- Antifungal Combinations against Candida albicans Biofilms In Vitro
- Chitin biosynthesis in Candida albicans grown in vitro and in vivo and its inhibition by nikkomycin Z.